Skip to main content

A worldwide technology outage is causing disruption to some State of Illinois online systems. We are aware of this issue and are diligently working on restoration.

Notice of Privacy Incident
We are offering two in-person Healthchoice Illinois Listening Sessions allow you the opportunity to talk about your experiences with HealthChoice Illinois managed care. Please be sure to register for one of these important events.

Drugs and Therapeutics (D & T) Committee Drugs Under Review for: September 23, 2009

Drug Name	Review Type	Class	Manufacturer
Besivance	New Drug Initial Review	Ophthalmic Fluoroquinolone	Bausch & Lomb
Nascobal	New Drug Initial Review	Vitamin	Par
Santyl Ointment	New Drug Initial Review	Wound Care	Healthpoint
Toviaz	New Drug Initial Review	Urinary Anti-Incontinence	Pfizer
Momexin	New Drug Initial Review	Topical Corticosteroid	JSJ
Nucynta	New Drug Initial Review	Narcotic	Ortho-McNeil-Janssen/J&J
Bromfed DM	New Drug Initial Review	Non-Narcotic Cough/Cold	Morton Grove/Wockhardt
Invega Sustenna	New Drug Initial Review	Atypical Antipsychotic	Ortho-McNeil-Janssen/J&J
Savella	New Drug Initial Review	SNRI	Forest
Multaq	New Drug Initial Review	Antiarrhythmic	Sanofi Aventis
Saphris	New Drug Initial Review	Atypical Antipsychotic	Schering-Plough
Adcirca	New Drug Initial Review	Pulmonary Arterial Hypertension	United Therapeutics
Onglyza	New Drug Initial Review	DPP4 Inhibitor	BMS
Ulesfia	New Drug Initial Review	Pediculocide	Sciele
Moxatag	New Drug Appeal	Antibiotic	MiddleBrook
PegIntron	PDL Appeal	Hepatitis C	Schering-Plough
Advair	PDL Appeal	Inhaled Steroid	GlaxoSmithKline